Ozgur Kemal, Berkkanoglu Murat, Bulut Hasan, Humaidan Peter, Coetzee Kevin
Antalya IVF, Antalya, 07080, Turkey.
The Fertility Clinic, Skive Regional Hospital and Faculty of Health, Aarhus University, Aarhus, 7800, Denmark.
J Assist Reprod Genet. 2016 Feb;33(2):207-14. doi: 10.1007/s10815-015-0639-3. Epub 2015 Dec 23.
In segmented ART treatment or so-called 'freeze-all' strategy fresh embryo transfer is deferred, embryos cryopreserved, and the embryo transferred in a subsequent frozen embryo transfer (FET) cycle. The purpose of this cohort study was to compare a GnRHa depot with an oral contraceptive pill (OCP) programming protocol for the scheduling of an artificial cycle FET (AC-FET) after oocyte pick-up (OPU).
This retrospective cohort study was conducted on prospectively performed segmented ART cycles performed between September 2014 and April 2015. The pregnancy, treatment duration, and cycle cancellation outcomes of 170 OCP programmed AC-FET cycles were compared with 241 GnRHa depot programmed AC-FET cycles.
No significant difference was observed in the per transfer pregnancy and clinical pregnancy rates between the OCP and GnRHa groups, 72.0 versus 77.2 %, and 57.8 versus 64.3 %, respectively. Furthermore, the early pregnancy loss rate was non-significantly different between the OCP and GnRH protocol groups, 19.8 versus 16.7 %, respectively. However, nine (5.29 %) cycles were cancelled due to high progesterone in the OCP protocol group, while no cycles were cancelled in the GnRHa protocol group and the time taken between OPU and FET was 19 days longer (54.7 vs 35.6 days) in the OCP protocol compared to the GnRHa protocol.
The results of this AC-FET programming study suggests that the inclusion of GnRHa depot cycle programming into a segmented ART treatment will ensure pregnancy, while significantly reducing treatment duration and cycle cancellation.
在分段辅助生殖技术(ART)治疗或所谓的“全冷冻”策略中,新鲜胚胎移植被推迟,胚胎被冷冻保存,然后在随后的冷冻胚胎移植(FET)周期中进行胚胎移植。本队列研究的目的是比较促性腺激素释放激素激动剂(GnRHa)长效注射剂与口服避孕药(OCP)预处理方案在取卵(OPU)后安排人工周期FET(AC-FET)的情况。
本回顾性队列研究针对2014年9月至2015年4月期间前瞻性进行的分段ART周期。将170个OCP预处理的AC-FET周期与241个GnRHa长效注射剂预处理的AC-FET周期的妊娠、治疗持续时间和周期取消结局进行比较。
OCP组和GnRHa组每次移植的妊娠率和临床妊娠率无显著差异,分别为72.0%对77.2%和57.8%对64.3%。此外,OCP组和GnRHa方案组的早期妊娠丢失率无显著差异,分别为19.8%对16.7%。然而,OCP方案组有9个(5.29%)周期因孕酮水平高而取消,而GnRHa方案组没有周期取消,且与GnRHa方案相比,OCP方案中OPU和FET之间的时间长19天(54.7天对35.6天)。
本AC-FET预处理研究结果表明,在分段ART治疗中纳入GnRHa长效注射剂周期预处理可确保妊娠,同时显著缩短治疗持续时间并减少周期取消。